HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German OTC Market 2021: Firms Must Adapt To New E-Commerce And Product Portfolio Realities

Executive Summary

In Germany, the coronavirus accelerated the shift towards online pharmacy and has strengthened certain OTC categories in 2020. Sales of hand sanitizers and vitamin and mineral supplements jumped while cough, cold and flu purchases weakened. Exploring the 2020 data, Sempora Consulting offers its advice for companies looking to adapt their strategies to the new reality. 

You may also be interested in...



French OTC Sales Tumble In 2020

Our infographic explores a difficult 2020 for France's self-care market, as OTC drug sales slumped 9.4%. It wasn't all doom and gloom for the sector though as sales of both OTC devices and supplements were boosted by the COVID-19 pandemic.

COVID Brings Bubbling Beauty Trends To A Boil

Beauty market analysts offer insight on the e-commerce explosion, new levels of conscious consumerism, product innovations and more.

US Consumer Health 2020 News: ’60 Minutes’ Probiotic Dip Tops Switches, Monograph, Pandemic

Supplement industry’s bullseye on “60 Minutes” after its June segment critical of probiotic health benefits generated the most reads for a US consumer health and overall for HBW Insight articles in 2020. Articles about COVID-19 enforcement actions weren’t as widely read as coverage of FDA’s reorganization in its OTC drug offices and its approvals of additional ingredients to be available OTC.

Related Content

Topics

UsernamePublicRestriction

Register

OM017181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel